ArticleBMC ophthalmology2020

Ripasudil alleviated the inflammation of RPE cells by targeting the miR-136-5p/ROCK/NLRP3 pathway.

Zhao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.